LPL and alkaline phosphatase measurement: The study highlights the implications of using heparin, which releases lipoprotein lipase and may generate NEFAs when used alone or during plasmapheresis to treat HTG-AP, since several studies showed no improvement in outcomes in such scenarios despite a reduction in serum TGs (40–43).